GLP-1 receptor agonists are associated with a lower risk of dementia than DPP-4 inhibitors in dialysis patients with diabetes.

A federal vaccine advisory committee has voted to change the recommendation that all US newborns receive the hepatitis B vaccine at birth.

Dozens of units of counterfeit Ozempic (semaglutide 1mg injection) were seized by the FDA, according to a drug safety alert issued by the Agency.

Clustering youth-onset T2D reveals distinct groups but offers no better clinical utility than simple measures for predicting complications.

The World Health Organization (WHO) is looking to digital tech devices to enhance health and wellness across the globe.

Researchers have found that, over the last 2 decades, the incidence of pregnancy-related cardiovascular complications has increased.

A new alert from the FDA warns that some sensors from Abbott may give incorrect blood sugar readings, which could lead to adverse events.

GLP-1 RAs are safe and efficacious for adults with IBD, with no increased risk for flare-ups, hospitalization, corticosteroid use, or operation.

Inhaled Technosphere insulin (TI) failed to meet noninferiority for HbA1c vs subcutaneous rapid-acting analog (RAA) insulin in youth.

The new World Health Organization guideline supports using GLP-1 drugs for long-term obesity care, emphasizing lifestyle, behavioral therapy.

Planetary Health Diet (PHD) adherence is linked to better weight outcomes and lower myocardial infarction risk in women with prior GD.

The FDA has accepted for Priority Review the NDA for baxdrostat for the add-on treatment of uncontrolled or treatment resistant hypertension in adults.